Mushroom Toxicity Differential Diagnoses

  • Author: Rania Habal, MD; Chief Editor: Michael R Pinsky, MD, CM, FCCP, FCCM   more...
 
Updated: Jul 27, 2011
 
 

Differential Diagnoses

Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Rania Habal, MD  Assistant Professor, Department of Emergency Medicine, New York Medical College

Disclosure: Nothing to disclose.

Coauthor(s)

Jorge A Martinez, MD, JD  Clinical Professor, Department of Internal Medicine, Louisiana State University School of Medicine; Clinical Instructor, Department of Surgery, Tulane School of Medicine

Jorge A Martinez, MD, JD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Cardiology, American College of Emergency Physicians, American College of Physicians, and Louisiana State Medical Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Laurie Robin Grier, MD  Medical Director of MICU, Professor of Medicine, Department of Emergency Medicine, Anesthesiology and OBGYN, Section of Pulmonary and Critical Care Medicine, Louisiana State University Health Science Center at Shreveport

Laurie Robin Grier, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Society for Parenteral and Enteral Nutrition, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Daniel R Ouellette, MD, FCCP  Associate Professor of Medicine, Wayne State University School of Medicine; Consulting Staff, Pulmonary Disease and Critical Care Medicine Service, Henry Ford Health System

Daniel R Ouellette, MD, FCCP is a member of the following medical societies: American College of Chest Physicians and American Thoracic Society

Disclosure: Boehringer Ingleheim Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching; Astra Zeneca Honoraria Speaking and teaching

Timothy D Rice, MD  Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, St Louis University School of Medicine

Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians

Disclosure: Nothing to disclose.

Chief Editor

Michael R Pinsky, MD, CM, FCCP, FCCM  Professor of Critical Care Medicine, Bioengineering, Cardiovascular Disease and Anesthesiology, Vice-Chair of Academic Affairs, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center

Michael R Pinsky, MD, CM, FCCP, FCCM is a member of the following medical societies: American College of Chest Physicians, American College of Critical Care Medicine, American Heart Association, American Thoracic Society, Association of University Anesthetists, European Society of Intensive Care Medicine, Shock Society, and Society of Critical Care Medicine

Disclosure: LiDCO Ltd Honoraria Consulting; iNTELOMED Intellectual property rights Board membership; Edwards Lifesciences Honoraria Consulting; Applied Physiology, Ltd Honoraria Consulting; Cheetah Medical Consulting fee Consulting

References

  1. Dhabolt John. Mushroom Poisons and Poisonous Mushrooms. The Puffball (Newsletter of the Willamette Valley Mushroom Society. 1993;16, No. 3:[Full Text].

  2. Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol (Phila). Dec 2010;48(10):979-1178. [Medline].

  3. Beug MW, Shaw M, Cochran KW. Summary of approximately 2000 reports in the NAMA registry. NAMA Case registry.

  4. West PL, Lindgren J, Horowitz BZ. Amanita smithiana mushroom ingestion: a case of delayed renal failure and literature review. J Med Toxicol. Mar 2009;5(1):32-8. [Medline].

  5. Tong TC, Hernandez M, Richardson WH 3rd, et al. Comparative treatment of alpha-amanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and silybin in a murine model. Ann Emerg Med. Sep 2007;50(3):282-8. [Medline].

  6. US Food and Drug Administration. FDA Drug Safety Communication: Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications. Available at http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm. Accessed July 27, 2011.

  7. Giannini L, Vannacci A, Missanelli A, et al. Amatoxin poisoning: a 15-year retrospective analysis and follow-up evaluation of 105 patients. Clin Toxicol (Phila). Jun-Aug 2007;45(5):539-42. [Medline].

  8. Amanita phalloides mushroom poisoning--Northern California, January 1997. MMWR Morb Mortal Wkly Rep. Jun 6 1997;46(22):489-92. [Medline].

  9. Barbato MP. Poisoning from accidental ingestion of mushrooms. Med J Aust. Jun 21 1993;158(12):842-7. [Medline].

  10. Beckurts KT, Holscher AH, Heidecke CD, et al. [The role of liver transplantation in the treatment of acute liver failure following Amanita phalloides poisoning]. Dtsch Med Wochenschr. Mar 21 1997;122(12):351-5. [Medline].

  11. Bedry R, Baudrimont I, Deffieux G, et al. Wild-mushroom intoxication as a cause of rhabdomyolysis. N Engl J Med. Sep 13 2001;345(11):798-802. [Medline].

  12. Bektas H, Schlitt HJ, Boker K, et al. [Indications for liver transplantation in severe amanita phalloides mushroom poisoning]. Chirurg. Oct 1996;67(10):996-1001. [Medline].

  13. Benjamin DR. Mushroom poisoning in infants and children: the Amanita pantherina/muscaria group. J Toxicol Clin Toxicol. 1992;30(1):13-22. [Medline].

  14. Berger KJ, Guss DA. Mycotoxins revisited: Part I. J Emerg Med. Jan 2005;28(1):53-62. [Medline].

  15. Berger KJ, Guss DA. Mycotoxins revisited: Part II. J Emerg Med. Feb 2005;28(2):175-83. [Medline].

  16. Bouget J, Bousser J, Pats B, et al. Acute renal failure following collective intoxication by Cortinarius orellanus. Intensive Care Med. 1990;16(8):506-10. [Medline].

  17. Butera R, Locatelli C, Coccini T, et al. Diagnostic accuracy of urinary amanitin in suspected mushroom poisoning: a pilot study. J Toxicol Clin Toxicol. 2004;42(6):901-12. [Medline].

  18. Danel VC, Saviuc PF, Garon D. Main features of Cortinarius spp. poisoning: a literature review. Toxicon. Jul 2001;39(7):1053-60. [Medline].

  19. de Haro L, Jouglard J, Arditti J, et al. [Acute renal insufficiency caused by Amanita proxima poisoning: experience of the Poison Center of Marseille]. Nephrologie. 1998;19(1):21-4. [Medline].

  20. Diaz JH. Evolving global epidemiology, syndromic classification, general management, and prevention of unknown mushroom poisonings. Crit Care Med. Feb 2005;33(2):419-26. [Medline].

  21. Diaz JH. Syndromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med. Feb 2005;33(2):427-36. [Medline].

  22. Enjalbert F, Rapior S, Nouguier-Soule J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40(6):715-57. [Medline].

  23. Fischbein CB, Mueller GM, Leacock PR, et al. Digital imaging: a promising tool for mushroom identification. Acad Emerg Med. Jul 2003;10(7):808-11. [Medline].

  24. Goldfrank LR. Mushrooms. Goldfrank's Toxicologic Emergencies. Eighth Edition. Goldfrank LR, Flom. 2006:1564-1575.

  25. Haddad LM, Winchester JF. Mushrooms. Clinical Management of Poisoning and Drug Overdose. 1998;365-374.

  26. Hall AH, Spoerke DG, Rumack BH. Mushroom poisoning: identification, diagnosis, and treatment. Pediatr Rev. Apr 1987;8(10):291-8. [Medline].

  27. Horn S, Horina JH, Krejs GJ, et al. End-stage renal failure from mushroom poisoning with Cortinarius orellanus: report of four cases and review of the literature. Am J Kidney Dis. Aug 1997;30(2):282-6. [Medline].

  28. Karlson-Stiber C, Persson H. Cytotoxic fungi--an overview. Toxicon. Sep 15 2003;42(4):339-49. [Medline].

  29. Kuwabara T, Arai A, Honma N, et al. [Acute encephalopathy among patients with renal dysfunction after ingestion of "sugihiratake", angel's wing mushroom--study on the incipient cases in the northern area of Niigata Prefecture]. Rinsho Shinkeigaku. Mar 2005;45(3):239-45. [Medline].

  30. Köppel C. Clinical symptomatology and management of mushroom poisoning. Toxicon. Dec 1993;31(12):1513-40. [Medline].

  31. Lampe KF, McCann MA. Differential diagnosis of poisoning by North American mushrooms, with particular emphasis on Amanita phalloides-like intoxication. Ann Emerg Med. Sep 1987;16(9):956-62. [Medline].

  32. Leathem AM, Purssell RA, Chan VR, et al. Renal failure caused by mushroom poisoning. J Toxicol Clin Toxicol. 1997;35(1):67-75. [Medline].

  33. Lincoff G, Mitchell DH. Toxic and Hallucinogenic Mushroom Poisoning: A Handbook For Physicians and Mushroom Hunters.

  34. McPartland JM, Vilgalys RJ, Cubeta MA. Mushroom poisoning. Am Fam Physician. Apr 1997;55(5):1797-800, 1805-9, 1811-2. [Medline].

  35. Montanini S, Sinardi D, Pratico C, et al. Use of acetylcysteine as the life-saving antidote in Amanita phalloides (death cap) poisoning. Case report on 11 patients. Arzneimittelforschung. Dec 1999;49(12):1044-7. [Medline].

  36. Pinson CW, Daya MR, Benner KG, et al. Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg. May 1990;159(5):493-9. [Medline].

  37. Respiratory illness associated with inhalation of mushroom spores--Wisconsin, 1994. MMWR Morb Mortal Wkly Rep. Jul 29 1994;43(29):525-6. [Medline].

  38. Rubik J, Pietraszek-Jezierska E, Kaminski A, et al. Successful treatment of a child with fulminant liver failure and coma caused by Amanita phalloides intoxication with albumin dialysis without liver transplantation. Pediatr Transplant. Jun 2004;8(3):295-300. [Medline].

  39. Saviuc P, Flesch F. [Acute higher funghi mushroom poisoning and its treatment]. Presse Med. Sep 20 2003;32(30):1427-35. [Medline].

  40. Saviuc PF, Danel VC, Moreau PA, et al. Erythromelalgia and mushroom poisoning. J Toxicol Clin Toxicol. 2001;39(4):403-7. [Medline].

  41. Schneider SM, Vanscoy G, Michelson EA. Failure of cimetidine to affect phalloidin toxicity. Vet Hum Toxicol. Feb 1991;33(1):17-8. [Medline].

  42. Schneider SM. Mushroom Toxicity. In: Auerbach PS, Geehr EC, eds. Management of Wilderness and Environmental Emergencies. 1988:891-907.

  43. Shakil AO, Mazariegos GV, Kramer DJ. Fulminant hepatic failure. Surg Clin North Am. Feb 1999;79(1):77-108. [Medline].

  44. Shi Y, He J, Chen S, et al. MARS: optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning--a case report. Liver. 2002;22 Suppl 2:78-80. [Medline].

  45. Warden CR, Benjamin DR. Acute renal failure associated with suspected Amanita smithiana mushroom ingestions: a case series. Acad Emerg Med. Aug 1998;5(8):808-12. [Medline].

  46. Warden CR, Benjamin DR. Acute renal failure associated with suspected Amanita smithiana mushroom ingestions: a case series. Acad Emerg Med. Aug 1998;5(8):808-12. [Medline].

  47. Winkelmann M, Stangel W, Schedel I, et al. Severe hemolysis caused by antibodies against the mushroom Paxillus involutus and its therapy by plasma exchange. Klin Wochenschr. Oct 1 1986;64(19):935-8. [Medline].

 
Previous
Next
 
Amanita phalloides.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.